Claritev Corp. (CTEV)
23.72
+2.41
(+11.31%)
USD |
NYSE |
Oct 02, 16:00
23.36
-0.36
(-1.52%)
After-Hours: 20:00
Claritev Enterprise Value : 5.073B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 5.073B |
| October 01, 2026 | 5.032B |
| September 30, 2026 | 5.029B |
| September 29, 2026 | 5.037B |
| September 28, 2026 | 5.051B |
| September 25, 2026 | 5.064B |
| September 24, 2026 | 5.066B |
| September 23, 2026 | 5.095B |
| September 22, 2026 | 5.170B |
| September 21, 2026 | 5.206B |
| September 18, 2026 | 5.193B |
| September 17, 2026 | 5.208B |
| September 16, 2026 | 5.239B |
| September 15, 2026 | 5.273B |
| September 14, 2026 | 5.288B |
| September 11, 2026 | 5.280B |
| September 10, 2026 | 5.293B |
| September 09, 2026 | 5.285B |
| September 08, 2026 | 5.309B |
| September 04, 2026 | 5.322B |
| September 03, 2026 | 5.333B |
| September 02, 2026 | 5.352B |
| September 01, 2026 | 5.337B |
| August 31, 2026 | 5.345B |
| August 28, 2026 | 5.338B |
| Date | Value |
|---|---|
| August 27, 2026 | 5.328B |
| August 26, 2026 | 5.307B |
| August 25, 2026 | 5.308B |
| August 24, 2026 | 5.290B |
| August 21, 2026 | 5.302B |
| August 20, 2026 | 5.248B |
| August 19, 2026 | 5.270B |
| August 18, 2026 | 5.274B |
| August 17, 2026 | 5.269B |
| August 14, 2026 | 5.316B |
| August 13, 2026 | 5.386B |
| August 12, 2026 | 5.269B |
| August 11, 2026 | 5.263B |
| August 10, 2026 | 5.248B |
| August 07, 2026 | 5.223B |
| August 06, 2026 | 5.125B |
| August 05, 2026 | 5.113B |
| August 04, 2026 | 5.118B |
| August 03, 2026 | 5.082B |
| July 31, 2026 | 5.055B |
| July 30, 2026 | 5.070B |
| July 29, 2026 | 5.067B |
| July 28, 2026 | 5.055B |
| July 27, 2026 | 5.040B |
| July 24, 2026 | 5.037B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| LataMed AI Corp. | 11.92M |
| SCWorx Corp. | -0.8929M |
| Health Catalyst, Inc. | 197.09M |
| GoodRx Holdings, Inc. | 1.358B |
| iSpecimen, Inc. | -2.529M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -59.23M |
| Revenue (Quarterly) | 257.48M |
| Total Expenses (Quarterly) | 316.70M |
| EPS Diluted (Quarterly) | -3.491 |
| Gross Profit Margin (Quarterly) | 30.72% |
| Profit Margin (Quarterly) | -23.00% |
| Earnings Yield | -71.69% |
| Operating Earnings Yield | 10.58% |
| Normalized Earnings Yield | -71.65 |